Whereas, the downregulation or complete deletion of TRAF6 alleviated cardiac hypertrophy and cardiac dysfunction along with a decrease in expression levels of hypertrophy markers (Ji et al., 2016). This evidence concerns the gene TRAF6 and cardiac hypertrophy.